Guest Blogs - Express Pharma

Manufacturing permissions after lapse of new drug status: A critical review

AI in pharma: Disruption, displacement, and a new digital dawn

Kyasanur Forest Disease – How far is a regulatory approved vaccine?

Guaranteeing continuity of medicine supply through AI innovation

AI and real-world evidence: The next frontier in clinical research

Even pills ask you to diet and exercise, India must rethink its shortcut to health

Beyond the PDF: Why biopharma’s communication must catch up with Its science

The high cost of compromise: Why patient safety must come first

Pharma tariff bombshell: Navigating challenges, building resilience

Cell therapy’s next chapter: Industry embraces in-vivo innovation